Kromek Group plc (AIM:KMK), a developer of radiation and bio-detection technology solutions, has received the first $25m payment under its enablement agreement with Siemens Medical Solutions USA.

Consulting firm Candesic is opening an office in New York to deepen its reach in the US market.

Apposite Capital-backed Kelso Pharma has acquired Milton Keynes-based pharma business, Alturix Holdings.